PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
31-Aug-2021 Vita 34 again achieves double-digit growth in revenues and earnings in the first half of the year Vita 34 AG
31-Aug-2021 Cassiopea SpA and Sun Pharma announce the expiry of the HSR Act process and the successful consummation of their Winlevi® (clascoterone cream 1%) agreement Cassiopea S.p.A.
31-Aug-2021 Relief Reports that U.S. Collaboration Partner has Announced a New Finding from Aviptadil Phase 2b/3 Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19 RELIEF THERAPEUTICS Holdings AG
27-Aug-2021 Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer. Clinerion Ltd.
27-Aug-2021 Immutep announces Chinese patent grant for LAG-3 antagonist antibody LAG525 Immutep
27-Aug-2021 Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type-2 diabetes AstraZeneca
27-Aug-2021 TestCard launches a partnership with Zava Online increasing accessibility to treatment by providing at-home UTI ‘Test and Treat’ service TestCard
27-Aug-2021 CluePoints partners with ZS to provide best-in-class RBQM expertise and technology, increasing clinical trial efficiency and improving patient outcomes CluePoints
27-Aug-2021 Kinaxis Partners With Exelixis to Advance Supply Chain Planning for Its Cancer Drug Portfolio Kinaxis® Inc.
27-Aug-2021 TILT Biotherapeutics Reports Publication on its Oncolytic Immunotherapy Platform in Pancreatic Cancer TILT Biotherapeutics
27-Aug-2021 Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021 Nordic Nanovector ASA
27-Aug-2021 UCB’s BIMZELX®▼ (bimekizumab) granted marketing authorisation by UK’s MHRA for the treatment of adults with moderate to severe plaque psoriasis UCB
27-Aug-2021 UCB showcases commitment to treatment and management of epilepsy at the 34th International Epilepsy Congress UCB
26-Aug-2021 MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory DLBCL MorphoSys AG
26-Aug-2021 Mateo Iglesias Vice President Marketing & Sales Sakura Finetek Europe Sakura Finetek Europe
26-Aug-2021 Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine Johnson & Johnson
26-Aug-2021 FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma Thermo Fisher Scientific
26-Aug-2021 Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older Pfizer and BioNTech
26-Aug-2021 STADA continues to outpace the market in H1 and strengthens basis for further growth STADA
26-Aug-2021 Eckert & Ziegler Starts Technetium-99 Delivery in Brazil Eckert & Ziegler Strahlen- und Medizintechnik AG